Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11911474 Delivery and formulation of engineered nucleic acids

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
January 5, 2021
0
Date of Patent
February 27, 2024
0
Patent Application Number
17141753
0
Patent Citations
‌
US Patent 10022435 Nucleic acid vaccines
0
‌
US Patent 10463751 Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
0
‌
US Patent 10501513 Modified polynucleotides for the production of oncology-related proteins and peptides
0
‌
US Patent 10577403 Modified polynucleotides for the production of secreted proteins
0
‌
US Patent 10898574 Delivery and formulation of engineered nucleic acids
0
‌
US Patent 10925935 Terminally Modified RNA
0
‌
US Patent 7691569 Methods and compositions for diagnosing and monitoring transplant rejection
0
‌
US Patent 8075780 Purification and concentration of synthetic biological molecules
0
‌
US Patent 8093367 Preparation and isolation of 5′ capped mRNA
0
‌
US Patent 8664194 Method for producing a protein of interest in a primate
0
•••
Patent Inventor Names
Sayda M. Elbashir
0
Antonin De Fougerolles
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11911474
0
Patent Primary Examiner
‌
Robert M Kelly
0

Find more entities like US Patent 11911474 Delivery and formulation of engineered nucleic acids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo